Actelion reports findings from phase III study of macitentan in PAH due to Eisenmenger syndrome Jan. 23, 2017
DSMB recommends continuation of Evgen's phase II trial of SFX-01 in subarachnoid hemorrhage Jan. 12, 2017
RSS